Table 1.
PCA3 Cutoff | Sensitivity (%) | Specificity (%) |
5 | 96 | 14 |
20 | 71 | 56 |
35 | 54 | 74 |
50 | 40 | 83 |
65 | 32 | 91 |
90 | 20 | 95 |
N = 570 men undergoing prostate biopsy; 36% biopsy positive.
PCA3, prostate cancer antigen 3.
Modified from Deras IL et al.6